Factors Associated with Cancer-Related Pain Requiring High-Dose Opioid Use in Palliative Cancer Patients

Background: There are no universal tools to predict the necessity of high-dose opioid use for cancer-related pain. Early recognition and interventions for intractable cancer pain could minimize the distress of palliative patients. Objective: We sought to identify the clinical factors associated with...

Full description

Bibliographic Details
Main Authors: Hidetoshi Sumimoto, Komaki Hayashi, Yuri Kimura, Akihito Nishikawa, Seiko Hattori, Chiaki Hasegawa, Hiroaki Morii, Koji Teramoto, Sachiyo Morita, Yataro Daigo
Format: Article
Language:English
Published: Mary Ann Liebert 2021-09-01
Series:Palliative Medicine Reports
Subjects:
Online Access:https://www.liebertpub.com/doi/full/10.1089/PMR.2021.0037
_version_ 1827374102740992000
author Hidetoshi Sumimoto
Komaki Hayashi
Yuri Kimura
Akihito Nishikawa
Seiko Hattori
Chiaki Hasegawa
Hiroaki Morii
Koji Teramoto
Sachiyo Morita
Yataro Daigo
author_facet Hidetoshi Sumimoto
Komaki Hayashi
Yuri Kimura
Akihito Nishikawa
Seiko Hattori
Chiaki Hasegawa
Hiroaki Morii
Koji Teramoto
Sachiyo Morita
Yataro Daigo
author_sort Hidetoshi Sumimoto
collection DOAJ
description Background: There are no universal tools to predict the necessity of high-dose opioid use for cancer-related pain. Early recognition and interventions for intractable cancer pain could minimize the distress of palliative patients. Objective: We sought to identify the clinical factors associated with high-dose opioid use in advanced cancer patients to recognize palliative patients who would develop intractable cancer pain, as early as possible. Setting/Subjects: Among 385 in-hospital cancer patients from April 1, 2014 to July 31, 2019, who were referred to the palliative care team for cancer-related pain, clinical factors significantly correlated to high-dose opioid use were retrospectively analyzed. Measurements: We conducted a multiple logistic regression analysis to identify variables significantly related to high-dose opioid use (>120?mg/day oral morphine equivalent dose). Results: Independent factors of high-dose opioid use included younger age (odds ratio [OR] 0.965, 95% confidence interval [CI] 0.944?0.986, p?=?0.001), respiratory cancers (OR 1.882, 95% CI 1.069?3.312, p?<?0.001), and opioid switch (OR 2.869, 95% CI 1.497?5.497, p?=?0.001). The percentage of correct classifications of the regression equation was 86.9%. Conclusions: Younger age, respiratory cancers, and opioid switch were related to high-dose opioid use. Our findings may help palliative caregivers to deal with intractable cancer pain in palliative patients, and thus relieve their distress.
first_indexed 2024-03-08T11:27:44Z
format Article
id doaj.art-4f36d8ea98cc44368c5397637a853499
institution Directory Open Access Journal
issn 2689-2820
language English
last_indexed 2024-03-08T11:27:44Z
publishDate 2021-09-01
publisher Mary Ann Liebert
record_format Article
series Palliative Medicine Reports
spelling doaj.art-4f36d8ea98cc44368c5397637a8534992024-01-26T04:53:06ZengMary Ann LiebertPalliative Medicine Reports2689-28202021-09-012123724110.1089/PMR.2021.0037Factors Associated with Cancer-Related Pain Requiring High-Dose Opioid Use in Palliative Cancer PatientsHidetoshi SumimotoKomaki HayashiYuri KimuraAkihito NishikawaSeiko HattoriChiaki HasegawaHiroaki MoriiKoji TeramotoSachiyo MoritaYataro DaigoBackground: There are no universal tools to predict the necessity of high-dose opioid use for cancer-related pain. Early recognition and interventions for intractable cancer pain could minimize the distress of palliative patients. Objective: We sought to identify the clinical factors associated with high-dose opioid use in advanced cancer patients to recognize palliative patients who would develop intractable cancer pain, as early as possible. Setting/Subjects: Among 385 in-hospital cancer patients from April 1, 2014 to July 31, 2019, who were referred to the palliative care team for cancer-related pain, clinical factors significantly correlated to high-dose opioid use were retrospectively analyzed. Measurements: We conducted a multiple logistic regression analysis to identify variables significantly related to high-dose opioid use (>120?mg/day oral morphine equivalent dose). Results: Independent factors of high-dose opioid use included younger age (odds ratio [OR] 0.965, 95% confidence interval [CI] 0.944?0.986, p?=?0.001), respiratory cancers (OR 1.882, 95% CI 1.069?3.312, p?<?0.001), and opioid switch (OR 2.869, 95% CI 1.497?5.497, p?=?0.001). The percentage of correct classifications of the regression equation was 86.9%. Conclusions: Younger age, respiratory cancers, and opioid switch were related to high-dose opioid use. Our findings may help palliative caregivers to deal with intractable cancer pain in palliative patients, and thus relieve their distress.https://www.liebertpub.com/doi/full/10.1089/PMR.2021.0037cancer-related painintractable cancer painhigh-dose opioid
spellingShingle Hidetoshi Sumimoto
Komaki Hayashi
Yuri Kimura
Akihito Nishikawa
Seiko Hattori
Chiaki Hasegawa
Hiroaki Morii
Koji Teramoto
Sachiyo Morita
Yataro Daigo
Factors Associated with Cancer-Related Pain Requiring High-Dose Opioid Use in Palliative Cancer Patients
Palliative Medicine Reports
cancer-related pain
intractable cancer pain
high-dose opioid
title Factors Associated with Cancer-Related Pain Requiring High-Dose Opioid Use in Palliative Cancer Patients
title_full Factors Associated with Cancer-Related Pain Requiring High-Dose Opioid Use in Palliative Cancer Patients
title_fullStr Factors Associated with Cancer-Related Pain Requiring High-Dose Opioid Use in Palliative Cancer Patients
title_full_unstemmed Factors Associated with Cancer-Related Pain Requiring High-Dose Opioid Use in Palliative Cancer Patients
title_short Factors Associated with Cancer-Related Pain Requiring High-Dose Opioid Use in Palliative Cancer Patients
title_sort factors associated with cancer related pain requiring high dose opioid use in palliative cancer patients
topic cancer-related pain
intractable cancer pain
high-dose opioid
url https://www.liebertpub.com/doi/full/10.1089/PMR.2021.0037
work_keys_str_mv AT hidetoshisumimoto factorsassociatedwithcancerrelatedpainrequiringhighdoseopioiduseinpalliativecancerpatients
AT komakihayashi factorsassociatedwithcancerrelatedpainrequiringhighdoseopioiduseinpalliativecancerpatients
AT yurikimura factorsassociatedwithcancerrelatedpainrequiringhighdoseopioiduseinpalliativecancerpatients
AT akihitonishikawa factorsassociatedwithcancerrelatedpainrequiringhighdoseopioiduseinpalliativecancerpatients
AT seikohattori factorsassociatedwithcancerrelatedpainrequiringhighdoseopioiduseinpalliativecancerpatients
AT chiakihasegawa factorsassociatedwithcancerrelatedpainrequiringhighdoseopioiduseinpalliativecancerpatients
AT hiroakimorii factorsassociatedwithcancerrelatedpainrequiringhighdoseopioiduseinpalliativecancerpatients
AT kojiteramoto factorsassociatedwithcancerrelatedpainrequiringhighdoseopioiduseinpalliativecancerpatients
AT sachiyomorita factorsassociatedwithcancerrelatedpainrequiringhighdoseopioiduseinpalliativecancerpatients
AT yatarodaigo factorsassociatedwithcancerrelatedpainrequiringhighdoseopioiduseinpalliativecancerpatients